Prestige Consumer Healthcare (PBH) Tops EPS, but the Details Tell a Less Impressive Story

Earnings beat boosted by accounting factors as organic growth guidance disappoints

Prestige Consumer Healthcare (PBH) reported non-GAAP EPS of $1.32 which topped the consensus estimates by 3 cps while revenue came in $7 million ahead of the Street estimate. However, the company cut the top end of its revenue guidance range before the quarter which takes some of the shine off the beat.

Fiscal 2025’s organic growth was only 1.2%, and PBH is guiding to only 1%-2% in fiscal 2026 which is less than inspiring in our view. More importantly, we continued to notice several accounting-related benefits that more than accounted for the earnings beat.

Let’s take a closer look at PBH’s 4Q numbers: